BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Press Releases

August 12, 2014BIO-Europe® 2014 kicks off its 20th year as life science partnering leader
Event will be held in Frankfurt, Germany this year
The twentieth annual BIO-Europe® international partnering conference will take place November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. "BIO-Europe has continued to be the leading European life science partnering event because of the high caliber companies that bring their teams to partner," said Florian Schoenhammer, Managing Direct...  more ►

August 1, 2014Spotlight on Frankfurt Business Facts The state of Hessen has top ranked cities: Frankfurt, Wiesbaden and Kassel are among the top 10 cities in Germany (based on WiWo City Ranking 2012). Frankfurt is Germany's major airport and leading hub in Europe with over 57.5 million passengers per year and 4,575 direct flight connections per week. Overall, 108 airlines fly to 295 destinations in 105 countries. There are tw...  more ►


partnering360® Blog

September 19, 2014 Who can you meet next week at BioPharm America™? Next week, 900 plus Pharmaceutical professionals, Innovators and investors will meet in Boston for the BioPharma America ™ event.  With the power of partneringONE®, these companies will be able to meet and form strategic relationships that will move the industry forward. Here are just a few of... more ►

September 17, 2014 FierceBiotech’s 2014 Fierce 15 winners to be announced live at BioPharm America™ FierceBiotech’s annual list of the Fierce 15 involves a hunt for the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven’t been done before. The result is fifteen privately held drug developers or platform biotechs with the potential... more ►

September 16, 2014 Innovation at Sanofi Sanofi looks for innovation in it’s drug portfolio in a variety of places – from the acquisitions they’ve made in their business to partnerships with venture capital, biotech and Pharma.  In a recent article at Insight, Gary J. Nabel, Senior VP, CSO and deputy to the President for... more ►

September 11, 2014 New therapeutic development models build researchers’ commercialization savvy Guest post from David Altman, Technology & Innovation Development Office, Boston Children’s Hospital Academic researchers and physician innovators are great at making research discoveries and developing inventions at an early stage. But if you were to fund them to turn their research... more ►

September 10, 2014 Broad Institute: Focus on cardiac arrhythmia Later this month at the BioPharm America™,  institutions from around the world will join us to present their latest innovations and discoveries. Today, we take a look at the Broad Institute and one of their latest innovative studies. Scientists came together to study heart arrhythmias and how... more ►



partnering360:Insight Latest headlines from partnering360:Insight

September 17, 2014 Vertex builds out BD group with sharp focus on in-licensing Both at BioPharm America™ in Boston and BIO-Europe® in Frankfurt, Vertex is on the hunt for research to late-stage development opportunities to further strengthen its pipeline through collaborations, part of a strategic shift meant to complement the ongoing internal research and development programs. more ►

September 9, 2014 Flagship Ventures explores the pharma innovation supply chain The care and feeding of the innovation supply chain is a primary focus for Flagship Ventures. While other venture capital firms are focusing on new financing options, this venture firm takes the more holistic approach of fostering innovation among early, disruptive platform companies—many of which they’ve created from scratch in-house—and forging relationships with larger firms that can take the platforms all the way to commercialization. more ►

September 5, 2014 Sanofi finds innovation in many places With ten therapeutic areas plus animal health, Sanofi’s R&D portfolio is well balanced to build upon the strengths of each of the franchises in its portfolio and to capitalize on innovative ideas and projects outside the company. more ►

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe EBD Group BIO BIO-Europe